GASTROINTESTINAL INVOLVEMENT AND ASSOCIATED FACTORS IN PATIENTS WITH SYSTEMIC SCLEROSIS
Main Article Content
Abstract
Objectives: (1) To assess the manifestations of gastrointestinal (GI) involvement in patients with systemic sclerosis (SSc) using the GIT 2.0 questionnaire.(2) To analyze factors associated with GI involvement in this patient population. Methods: A cross-sectional descriptive. Subjects: 70 patients diagnosed with SSc at the Rheumatology Center, Bach Mai Hospital and Hanoi Medical University Hospital from August 2024 to August 2025. Results: The average age of the study population was 58.1 ± 13.4 years, with 72.9% aged over 50 years. Most patients had a disease duration of less than two years (61.4%), and diffuse cutaneous SSc was the predominant subtype (67.1%). The majority of patients were female, with a female-to-male ratio of 4:1. GI involvement was mostly mild, but 68.5% had moderate-to-severe reflux and 24.3% had fecal soilage. Diffuse cutaneous SSc was associated with higher gastroesophageal reflux scores and poorer emotional well-being than limited cutaneous SSc. In addition, patients with moderate-to-very-severe gastroesophageal reflux symptoms had a higher prevalence of interstitial lung disease than those with absent or mild symptoms. Conclusion: Reflux subscales was the most frequently reported moderate to very severe GI symptom. Patients with diffuse cutaneous SSc and disease duration greater than 2 years had more severe GI involvement and greater mental health burden than those with limited cutaneous SSc and disease duration of 2 years or less
Article Details
Keywords
Systemic sclerosis, gastrointestinal involvement.
References
2. Elhai M, et al (2012). Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies. Rheumatology (Oxford)
3. Di Ciommo Fr, et al. Gastro-Intestinal Involvement In Systemic Sclerosis: Importance Of An Early Diagnosis Through Population Screening And The “UCLA SCTC GIT 2.0” Questionnaire. Annals Of The Rheumatic Diseases. 2023.
4. Murray CD, et al. Gastrointestinal involvement in systemic sclerosis: an update. Rheumatology (Oxford). 2006.
5. Meier FMP, et al. Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database. Ann Rheum Dis. 2012.